SION (Sionna Therapeutics) Total Assets: $305.04 Mil (As of Mar. 2026)


SION Sionna Therapeutics Inc SION
12 GF Score
Price $43.99
! 3 Warning Signs
View Full Analysis

What is Sionna Therapeutics Total Assets?

Sionna Therapeutics SION +5.64% 12 Total Assets is $305.04 Mil as of Mar. 2026. GuruFocus rates SION with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Sionna Therapeutics's Total Assets for the quarter that ended in Mar. 2026 was $305.04 Mil.

During the past 12 months, Sionna Therapeutics's average Total Assets Growth Rate was 135.70% per year. During the past 3 years, the average Total Assets Growth Rate was 166.50% per year.

During the past 4 years, Sionna Therapeutics's highest 3-Year average Total Assets Growth Rate was 166.50%. The lowest was 166.50%. And the median was 166.50%.

Total Assets is connected with ROA %. Sionna Therapeutics's annualized ROA % for the quarter that ended in Mar. 2026 was -33.95%. Total Assets is also linked to Revenue through Asset Turnover. Sionna Therapeutics's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Sionna Therapeutics  (NAS:SION) Total Assets Explanation

Total Assets is connected with ROA %.

Sionna Therapeutics's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-107.116/( (325.953+305.039)/ 2 )
=-107.116/315.496
=-33.95 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sionna Therapeutics's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (325.953+305.039)/ 2 )
=0/315.496
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sionna Therapeutics Total Assets Related Terms

Sionna Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Sionna Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sionna Therapeutics Total Assets Chart

Sionna Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Assets
87.37 51.95 185.75 325.95

Sionna Therapeutics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 369.67 352.05 339.27 325.95 305.04
SION
12GF Score
Sionna Therapeutics Inc SION
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sionna Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sionna Therapeutics's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=306.833+19.12
=325.95

Sionna Therapeutics's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=288.208+16.831
=305.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $305.04 Mil mean?
Sionna Therapeutics (SION) has a Total Assets of $305.04 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Sionna Therapeutics and its competitors.
Is Sionna Therapeutics' Total Assets too high?
Sionna Therapeutics' current Total Assets is $305.04 Mil. Overall, Sionna Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sionna Therapeutics' Total Assets compare to TYRA and RAPP?
Sionna Therapeutics' Total Assets of $305.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Sionna Therapeutics and its competitors. Sionna Therapeutics's current Total Assets is $305.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sionna Therapeutics stock overvalued right now?
Sionna Therapeutics (SION) has a current Total Assets of $305.04 Mil. The current Total Assets is $305.04 Mil. Sionna Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Sionna Therapeutics (SION), the current Total Assets is $305.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sionna Therapeutics Business Description

Address 21 Hickory Drive, Suite 500, Waltham, MA, USA, 02451
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
12GF Score

Get the complete analysis for SION

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.99
Price